Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 2 , Pages 147-152 , March 2008

Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate

  • Michele Albert, M.D.

      Affiliations

    • Department of Radiation Oncology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-508-979-5858; fax: +1-508-984-3535.
    • ,
  • Jun S. Song, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Delray Schultz, Ph.D.

      Affiliations

    • Department of Mathematics, Millersville University, Millersville, PA 17551, USA
    • ,
  • Robert A. Cormack, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Clare M. Tempany, M.D.

      Affiliations

    • Department of Radiology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Steve Haker

      Affiliations

    • Department of Radiology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Phillip M. Devlin, M.D.

      Affiliations

    • Department of Radiation Oncology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Clair Beard, M.D.

      Affiliations

    • Department of Radiation Oncology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Mark D. Hurwitz, M.D.

      Affiliations

    • Department of Radiation Oncology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Wonsuk W. Suh, M.D.

      Affiliations

    • Department of Radiation Oncology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Ferenc Jolesz, M.D.

      Affiliations

    • Department of Radiology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Anthony V. D’Amico, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA

Received 21 September 2006 ,Revised 11 March 2007 ,Accepted 15 March 2007.

References 

  1. Sylvester JE, Blasko JC, Grimm PD, et al. Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: The Seattle experience. Int J Radiat Oncol Biol Phys. 2003;57:944–952
  2. Grimm PD, Blasko JC, Sylvester JE, et al. 10-year biochemical (prostate-specific antigen) control of prostate cancer with I125 brachytherapy. Int J Radiat Oncol Biol Phys. 2001;51:31–40
  3. D’Amico AV, Cormack RA, Tempany CM, et al. Real time magnetic resonance image guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1998;42:507–516
  4. D’Amico AV, Tempany CM, Cormack RA, et al. Comparing PSA outcome following radical prostatectomy or magnetic resonance image-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology. 2003;62:1063–1067
  5. Seo PH, Clark JA, Mitchell SP, et al. Early symptoms and symptoms distress after standard ultrasound guided brachytherapy or MRI-guided brachytherapy in early stage prostate cancer. (Abstract 2377) Proc Am Soc Clin Oncol. 2001;20:157b
  6. Albert M, Tempany CM, Schultz D, et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer. 2003;98:949–954
  7. Gelblum DY, Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2000;48:119–124
  8. Hu K, Wallner K. Clinical course of rectal bleeding following I125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;41:263–265
  9. Kang SK, Chou RH, Dodge RK, et al. Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1995;53:99–103
  10. Wallner K, Roy J, Harrison LB. Dosimetric guidelines to minimize urethral and rectal morbidity following transperineal I125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1995;32:465–471
  11. Merrick GS, Butler WM, Dorsey AT, et al. Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;43:1021–1027
  12. Snyder KM, Stock RG, Hong SM, et al. Defining the risk of developing grade 2 proctitis following I125 prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001;50:335–341
  13. Cox JD, Stetz J, Pajak TF Toxicity criteria of the radiation therapy oncology group (RTOG) European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  14. Han BH, Wallner KE. Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications. Int. J. Cancer. 2001;96:372–378
  15. Waterman FM, Dicker AP. Probability of late rectal morbidity in I125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2003;55:342–353
  16. Shah JN, Enis RD. Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: Use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors. Int J Radiation Oncol Bio Phys. 2006;64:817–824
  17. National cancer institute cancer therapy evaluation program. Common terminology criteria for adverse events version 3.0 (NCI CTEP Website). http://ctep.info.nih.gov
  18. Smith S, Wallner KE, Domonitz JA, et al. Argon plasma coagulation for rectal bleeding after prostate brachytherapy. Int J Radiation Oncol Bio Phys. 2001;51:636–642
  19. Venkatesh KS, Ramanujam P. Endoscopic therapy for radiation proctitis-induced hemorrhage in patients with prostatic carcinoma using argon plasma coagulator application. Surg Endosc. 2002;16:707–710
  20. MIT Artificial Intelligence Lab and the Surgical Planning Lab at Brigham and Women’s Hospital (The 3D SLICER). http://www.slicer.org
  21. D’Amico AV, Manola J, McMahon , et al. A Prospective evaluation of rectal bleeding following dose escalated 3D conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization. Urology. 2006;67:780–784

PII: S1078-1439(07)00078-6

doi: 10.1016/j.urolonc.2007.03.026

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 2 , Pages 147-152 , March 2008

Article Tools

* Image Usage & Resolution